WHO Model Prescribing Information: Drugs Used in Skin Diseases
(1997; 132 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoPreface
Ver el documentoIntroduction
Abrir esta carpeta y ver su contenidoParasitic infections
Cerrar esta carpetaInsect and arachnid bites and stings
Ver el documentoMosquitos and other biting flies
Ver el documentoBees, wasps, hornets and ants
Ver el documentoBedbugs and reduviid bugs
Ver el documentoScorpions
Ver el documentoPoisonous spiders
Ver el documentoChiggers or harvest mites
Ver el documentoTicks
Abrir esta carpeta y ver su contenidoSuperficial fungal infections
Abrir esta carpeta y ver su contenidoSubcutaneous fungal infections
Abrir esta carpeta y ver su contenidoBacterial infections
Abrir esta carpeta y ver su contenidoViral infections
Abrir esta carpeta y ver su contenidoEczematous diseases
Abrir esta carpeta y ver su contenidoScaling diseases
Abrir esta carpeta y ver su contenidoPapulosquamous diseases
Ver el documentoCutaneous reactions to drugs
Abrir esta carpeta y ver su contenidoPigmentary disorders
Abrir esta carpeta y ver su contenidoPremalignant lesions and malignant tumours
Abrir esta carpeta y ver su contenidoPhotodermatoses
Abrir esta carpeta y ver su contenidoBullous dermatoses
Ver el documentoAlopecia areata
Ver el documentoUrticaria
Abrir esta carpeta y ver su contenidoConditions common in children
Ver el documentoAcne vulgaris
Ver el documentoPruritus
Ver el documentoTropical ulcers
Abrir esta carpeta y ver su contenidoAntimicrobial drugs
Abrir esta carpeta y ver su contenidoAntifugal drugs
Abrir esta carpeta y ver su contenidoAntiseptic agents
Abrir esta carpeta y ver su contenidoKeratoplastic and keratolytic agents
Abrir esta carpeta y ver su contenidoScabicides and pediculicides
Abrir esta carpeta y ver su contenidoAnti-inflammatory and antipruritic drugs1
Abrir esta carpeta y ver su contenidoAntiallergics and drugs used in anaphylaxis
Abrir esta carpeta y ver su contenidoUltraviolet radiation-blocking agents (sunscreens)
Abrir esta carpeta y ver su contenidoMiscellaneous drugs
Abrir esta carpeta y ver su contenidoAnnex
Ver el documentoSelected WHO Publications of Related Interest
Ver el documentoBack cover
 

Poisonous spiders

Poisonous spiders are endemic in the tropics and the southern hemisphere where they typically inhabit woodpiles, outhouses and dark corners of garages and houses. Localized pain, swelling and erythema occur within 30 minutes of the bite. Abdominal cramps, which may simulate an acute condition requiring immediate surgery, are an indication of dissemination of the venom. In severe cases, intense localized pain and vasoconstriction can be followed by oedema and local necrosis. Complications, which are often fatal, include acute haemolysis, pulmonary oedema and renal insufficiency.

Prevention and management

Indoor spraying with pyrethroids is highly effective as a control measure. After being bitten, the patient should remain as still as possible, since movement accelerates dissemination of the venom. Specific antivenoms are of value when the species of spider is known. Otherwise, analgesics and muscle relaxants should be given to relieve pain and muscular spasms. Oral corticosteroids, if administered within 24 hours of the attack, are claimed to reduce the risk of local necrosis and the incidence of disfiguring scars.

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 19 enero 2012